Rankings
▼
Calendar
CGEM Q1 2022 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$894M
Q1 2022 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$33M
Net Income
-$12M
EPS (Diluted)
$-0.27
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$437M
Total Liabilities
$18M
Stockholders' Equity
$419M
Cash & Equivalents
$76M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$19M
-100.0%
Gross Profit
$0
$19M
-100.0%
Operating Income
-$33M
$1M
-2480.2%
Net Income
-$12M
-$70,000
-17182.9%
← FY 2022
All Quarters
Q2 2022 →